Association of Tuberculosis Risk With the Degree of Tuberculin Reaction in HIV-Infected Patients

作者: Enrico Girardi , Giorgio Antonucci , Giuseppe Ippolito , Mario C Raviglione , Elisabetta Rapiti

DOI: 10.1001/ARCHINTE.1997.00440280129013

关键词:

摘要: Background: The risk of developing active tuberculosis associated with a different size induration to purified protein derivative (PPD) has not been prospectively assessed among individuals infected human immunodeficiency virus (HIV). quantification this is important more appropriately identify candidates for preventive therapy tuberculosis. Methods: A prospective, multicenter, cohort study on in HIV-infected patients was conducted 23 infectious disease units public hospitals Italy. Two thousand six hundred ninety-five were enrolled the study. Of these, 1054 who nonanergic at time entry included present analysis. median duration follow-up 102 weeks. main outcome measure diagnosis confirmed by isolation Mycobacterium culture. Results: Among 252 PPD reactivity, an 2 4 mm had CD4 + lymphocyte count 0.34X10 9 /L (interquartile [IQ] range, 0.14X 10 -0.56X ), those response 5 9mm 0.38X10 /L(IQrange, 0.24X10 and or higher 0.37X (IQ 0.23X -0.52X10 ) ( P =.38). Compared 802 PPD-negative patients, hazard ratios 2.1 (95% confidence interval [CI], 0.2-18.3) 55 mm, 5.7 CI, 1.6-19.8) 128 23.1 7.8-68.6) 69 higher. Conclusions: degree tuberculin does appear reflect immunosuppression strongly correlated subsequent incidence To are increased may benefit from therapy, appears be appropriate cutoff point. Arch Intern Med. 1997;157:797-800

参考文章(14)
Ferebee Sh, Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibliotheca tuberculosea. ,vol. 26, pp. 28- 106 ,(1970)
Robin E. Huebner, Tuberculin skin testing and the HIV epidemic. JAMA. ,vol. 267, pp. 409- 410 ,(1992) , 10.1001/JAMA.1992.03480030087044
M. P. Johnson, J. S. Coberly, H. C. Clermont, R. E. Chaisson, H. L. Davis, P. Losikoff, A. J. Ruff, R. Boulos, N. A. Halsey, Tuberculin skin test reactivity among adults infected with human immunodeficiency virus The Journal of Infectious Diseases. ,vol. 166, pp. 194- 198 ,(1992) , 10.1093/INFDIS/166.1.194
R. E. Huebner, M. F. Schein, J. B. Bass, The tuberculin skin test Clinical Infectious Diseases. ,vol. 17, pp. 968- 975 ,(1993) , 10.1093/CLINIDS/17.6.968
S. Moreno, J. Baraia-Etxaburu, P. Miralles, J. Berenguer, D. Cosín, J. C.L. Bernaldo de Quriós, Tuberculin reaction size in patients infected with HIV. AIDS. ,vol. 9, pp. 1289- 1290 ,(1995) , 10.1097/00002030-199511000-00015
J. P. Narain, G. Slutkin, H. G. ten Dam, A. Kochi, Preventive tuberculosis chemotherapy in HIV infection: a priority for study AIDS. ,vol. 6, pp. 744- 746 ,(1992) , 10.1097/00002030-199207000-00024
P.E.M Fine, J.A.C Sterne, J.M Pönnighaus, R.J.W Rees, Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity The Lancet. ,vol. 344, pp. 1245- 1249 ,(1994) , 10.1016/S0140-6736(94)90748-X
Neil MH Graham, Kenrad E Nelson, Liza Solomon, Margaret Bonds, Rosetta T Rizzo, Joseph Scavotto, Jacqueline Astemborski, David Vlahov, Prevalence of Tuberculin Positivity and Skin Test Anergy in HIV-1—Seropositive and —Seronegative Intravenous Drug Users JAMA. ,vol. 267, pp. 369- 373 ,(1992) , 10.1001/JAMA.1992.03480030047035
Giorgio Antonucci, Enrico Girardi, Mario C Raviglione, Giuseppe Ippolito, Paolo Almi, Gioacchino Angarano, Orlando Armignacco, Sergio Babudieri, Nazario Bevilacqua, Alessandra Bini, Patrizia Bottura, Evangelo Boumis, Paolo Costigliola, Antonio Chirianni, Giovanni Di Perri, Isabella Errante, Marco Libanore, Elio Manzillo, Lorenzo Minoli, Pasquale Narciso, Gabriella Pagano, Gianpietro Pellizzer, Elisabetta Rapiti, Stefano Rusconi, Domenico Santoro, Eliana Savalli, Marcello Tavio, Antonio Traverso, Pierluigi Viale, Risk Factors for Tuberculosis in HIV-lnfected Persons: A Prospective Cohort Study JAMA. ,vol. 274, pp. 143- 148 ,(1995) , 10.1001/JAMA.1995.03530020061033
J.W. Pape, S.S. Jean, J.L. Ho, A. Hafner, W.D. Johnson, Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection The Lancet. ,vol. 342, pp. 268- 272 ,(1993) , 10.1016/0140-6736(93)91817-6